Berberine Improves Cognitive Impairment by Simultaneously Impacting Cerebral Blood Flow and β-Amyloid Accumulation in an APP/tau/PS1 Mouse Model of Alzheimer’s Disease. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.